Comparing tumour heterogeneity in primary tumour, circulating tumour cells and its metastases

• Conditions: lungcancer; 10027655; 10029107

• Registration Number: NL-OMON45251
• Lead Sponsor: niversitair Medisch Centrum Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 11 June 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 50

Inclusion Criteria

1. Patients with a histologically/cytologically proven lung cancer.
2. Patients have to have a non-curable disease state, without curative treatment options
3. Signed informed consent of patient
4. Patients family has asserted their acceptance of the patients participation

Exclusion Criteria

none

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>immunohistochemistry and genome sequencing with specific mutations and<br /><br>mutational load. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not applicable</p><br>